Stability of peptide-condensed plasmid DNA formulations.

Low molecular weight homogeneous peptides were used to form peptide/DNA condensates. A peptide possessing 18 lysines was found to protect plasmid DNA from serum endonuclease and sonicative-induced degradation whereas a shorter peptide possessing 8 lysines dissociated in 0.1 M sodium chloride and failed to protect DNA from enzymatic degradation. Peptide-condensed DNA showed no change in the ratio of supercoiled to circular DNA following 100 W sonication for up to 60 s and was able to transfect HepG2 cells with equivalent efficiency as untreated condensed plasmid DNA. Alternatively, uncondensed plasmid DNA was rapidly fragmented by sonication and serum endonucleases and resulted in negligible gene expression following condensation with peptide. Cationic lipid/DNA complexes were only partially effective at stabilizing DNA in serum compared to the complete stabilization afforded by peptide/DNA condensation. These results indicate that the stabilization afforded by condensation with a peptide protects DNA during formulation and preserves its structure in serum. These functions are important to achieve optimal gene expression from a nonviral gene delivery system.

[1]  A. Ichinose,et al.  Binding of Cationic α-Helical Peptides to Plasmid DNA and Their Gene Transfer Abilities into Cells* , 1997, The Journal of Biological Chemistry.

[2]  N. Weiner,et al.  Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations in vivo. , 1997, Journal of pharmaceutical sciences.

[3]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[4]  R. Scheule,et al.  Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes. , 1997, Human gene therapy.

[5]  K. Rice,et al.  Peptide-mediated gene delivery: influence of peptide structure on gene expression. , 1997, Bioconjugate chemistry.

[6]  P. Godowski,et al.  Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. , 1996, Journal of pharmaceutical sciences.

[7]  Leaf Huang,et al.  Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer (*) , 1996, The Journal of Biological Chemistry.

[8]  M. Bally,et al.  Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. , 1996, Journal of pharmaceutical sciences.

[9]  M. Wolfert,et al.  Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA. , 1996, Gene therapy.

[10]  P. Cheng,et al.  Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. , 1996, Human gene therapy.

[11]  Leaf Huang,et al.  Potentiation of cationic liposome-mediated gene delivery by polycations. , 1996, Biochemistry.

[12]  J. C. Perales,et al.  Receptor-mediated gene transfer into macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Parker,et al.  Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. , 1995, Human gene therapy.

[14]  K. Rice,et al.  Targeted gene delivery with a low molecular weight glycopeptide carrier. , 1995, Bioconjugate chemistry.

[15]  J. Philippot,et al.  A new cationic liposome encapsulating genetic material. A potential delivery system for polynucleotides. , 1995, European journal of biochemistry.

[16]  M. Monsigny,et al.  Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. , 1993, Nucleic acids research.

[17]  E. B. Lindblad,et al.  Ultrasonic degradation of DNA. , 1989, DNA.

[18]  M. Kunitz CRYSTALLINE DESOXYRIBONUCLEASE: I. ISOLATION AND GENERAL PROPERTIES SPECTROPHOTOMETRIC METHOD FOR THE MEASUREMENT OF DESOXYRIBONUCLEASE ACTIVITY , 1950 .

[19]  R. Walther,et al.  Genetic manipulation of rat hepatocytes in vivo. Implications for a therapy model of type-1 diabetes. , 1990, Biomedica biochimica acta.